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ABSTRACT 
Background: Portal hypertension is a major risk factor for hepatic failure or bleeding in 
patients who have undergone hepatectomy, but it cannot be measured indirectly. We 
attempted to evaluate the intra-operative ultrasonography parameters that correlate with 
portal pressure (PP) in patients undergoing hepatectomy. 
Methods: We examined 30 patients in whom portal pressure was directly measured 
during surgery. The background liver conditions included chronic viral liver disease in 
seven patients, chemotherapy associated steatohepatitis in four patients, fatty liver in one 
patient, hepatolithiasis in one patient, obstructive jaundice in one patient and a normal 
liver in 16 patients. A multivariate logistic analysis and linear regression analysis were 
conducted to develop a predictive formula for PP. 
Results: The mean PP was 10.4±4.1 mmHg. The PP tended to be increased in patients 
with chronic viral hepatitis. A univariate analysis identified the association of the six 
following parameters with PP: the platelet count and the maximum (max), minimum 
(min), endo-diastolic, peak-systolic and mean velocity in the portal vein (PV) flow. Using 
multiple linear regression analysis, the predictive formula using the PV max and min was 
as follows: Y (estimated PP) = 18.235 -0.120x (PV max.(m/s)) -0.364x (PV min). The 
calculated PP (10.44±2.61 mmHg) was nearly the same as the actual PP (10.43±4.07 
mmHg). However, there was no significant relationship between the calculated PP and 
the intra-operative blood loss and posthepatectomy morbidity.  
Conclusion: This formula, which uses ultrasonographic Doppler flow parameters, 
appears to be useful for predicting portal pressure. 
Keywords: Hepatectomy, Intra-operative ultrasonography, Doppler-Portal pressure
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1. Introduction 
The operative morbidity and mortality rates in patients who undergo hepatic resections 
have decreased in recent years due to improvements in both the preoperative evaluation 
of the liver’s functional reserve and in perioperative management [1]. Portal hypertension 
remains a lethal operative risk in patients with liver dysfunction, such as cirrhosis, and 
should be carefully evaluated [2]. However, portal pressure (PP) can be measured directly 
by the insertion of a catheter via a trans-hepatic or trans-intestinal venous approach [3, 4]. 
This approach is an invasive and complicated measure, requiring either puncture of the 
liver or laparotomy. PP cannot currently be measured using indirect tests. In cases where 
evaluation is performed for pulmonary hypertension, the gradient flow velocity or the 
volume of the cardiac tricuspid valve on ultrasonography can be used to predict the 
pulmonary arterial pressure [5]. In addition, the gradient of the hepatic venous-portal 
pressure can be evaluated by various means [6-8]. However, indirectly evaluating PP 
itself remains difficult. Some investigators have attempted to identify the factors 
associated with portal hypertension [9-11], but clear predictors of PP have yet to be 
clarified.  
Ultrasonography can be easily performed before or during surgery and can be used to 
measure the velocity, resistant index, etc. [12]. Intra-operative ultrasonography (IOUS) is 
an essential tool to determine tumor locations, surgical margins and adjacent vascular 
involvement. The accuracy of determining the flow Doppler by IOUS is high (4, 5). The 
flow Doppler’s ultrasonographic parameters reflect the dynamics of the hepatic inflow 
and outflow, which may be associated with both the PP and the background liver status 
[13, 14]. To the best of our knowledge, no indirect prediction of PP using 
ultrasonographic parameters has yet been reported. The analysis of PP using a predictive 
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formula would be useful for evaluating operative risks and reducing portal 
hypertension-related hepatic complications in patients who undergo hepatectomy. We 
therefore attempted to examine the intra-operative ultrasonography parameters that 
correlate with PP in patients for whom PP could be measured directly during operation. 
We hypothesized that IOUS Doppler is a useful tool for evaluating hepatic 
vascularization and for accurately evaluating the correlation between the hepatic flow and 
the PP during surgery, which is important for evaluating portal hypertension. 
The aim of the present preliminary study was to clarify aspects of IOUS that may 
predict portal pressure. For this purpose, as a preliminary study, the present study 
examined the relationships between the portal pressure and ultrasonographic parameters 
in 30 patients with various liver diseases in whom PP was directly measured to predict 
true PP.  
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2. Methods 
2.1. Patients 
Subjects comprised 30 patients (21 men and nine women) with or without liver disease 
who underwent hepatectomies in the Department of Surgical Oncology at Nagasaki 
University Graduate School of Biomedical Sciences between February 2013 and January 
2014. The 32 patients were consecutively entered for the present study and, however, two 
patients (metastatic liver carcinoma and hepatocellular carcinoma) could not technically 
underwent measuring the direct portal pressure because of the post-colectomy and 
post-cholecystectomy adhesions, respectively. The mean (±standard deviation (SD)) age 
was 66±13 years (range, 30-85 years). The liver diseases warranting hepatic resection 
included hepatocellular carcinomas in 14 patients, metastatic liver carcinomas in eight 
patients, intrahepatic cholangiocarcinomas in three patients and bile duct carcinomas in 
five patients. The background liver condition was chronic viral liver disease in seven 
patients (including cirrhosis in two), chemotherapy associated steatohepatitis in four 
patients, fatty liver in one patient, hepatolithiasis in one patient, obstructive jaundice in 
one patient and normal livers in 16 patients. 
In our hospital, the volume of the liver to be resected is estimated before surgery 
based on the results of the ICG retention rate at 15 min (ICGR15) using Takasaki’s 
formula [15]. The liver volume, excluding the tumor, is measured by computed 
tomography (CT) volumetry [16]. Since 2004, we have modified our criteria and have 
used 99mTc-GSA scintigraphy and the associated functional hepatic volumetry, serum HA 
level and prothrombin activity based on ICGR15 testing to determine the extent of a 
hepatectomy [17]. In this cohort, we performed limited resections in five patients, a 
segmentectomy or sectionectomy in 12 patients, a lobectomy or more extended 
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lobectomy in 10 patients and a pancreaticoduodenectomy in three patients. The study 
design was approved by the ethics review board at our university hospital, and informed 
consent for the data collection was obtained from each patient prior to participation. 
 
2.2.  Evaluated parameters 
The clinical data, results of conventional liver function tests and surgical data were 
analyzed. The ICG was injected intravenously at a dose of 0.5 mg/kg body weight, and 
the 15-min retention rate was measured using a photopiece applied to the fingertip 
(RK-1000; Sumitomo Electric, Tokyo, Japan) without blood sampling [17, 18]. Patients 
received 3 mg (185 MBq) of 99mTc-GSA (Nihon Medi-Physics, Nishinomiya, Japan) as a 
bolus dose into the antecubital vein. The clearance index of 99mTc-GSA (HH15) and the 
hepatic uptake ratio of 99mTc-GSA (LHL15; the count ratio in the liver compared with the 
sum of the count ratios for the heart and liver at 15 min after the injection of 99mTc-GSA) 
were calculated after the injection of 99mTc-GSA [18]. The HA was assayed using the 
sandwich binding protein assay (SRL, Tokyo, Japan). The normal value of the serum HA 
as determined by the laboratory data of SRL is <50 ng/ml [135, 17, 18]. Analysis of the 
histological fibrosis (staging) and necro-inflammatory responses (grading) were followed 
by calculating the Knodell score. [19]. 
 
2.3.  Direct measurement of portal pressure and the IOUS Doppler  
A 24-Fr venous catheter was inserted intra-operatively via the portal trunk, and the tip 
of the catheter was placed at the major portal trunk. Then, the catheter was connected 
with the anesthesia pressure monitoring system, and the PP was directly measured. The 
IOUS examination was performed using an XarioTM XG (Toshiba Medical Systems, 
7 
Revised May 1/2014 
Tokyo, Japan) and a micro-convex probe (PVT-375BT, 3.5 MHz, Toshiba) and an 
inter-operative probe (PLT-705BTH, 7.5 MHz). All IOUS were performed by surgeons to 
help with determining the indication for hepatectomy. First, we examined the 
two-dimensional (2D) images of the tumor and its location and also the Color Doppler 
Images of the tumor vasculature (12). For tumors located on the liver’s surface, the liver 
was covered with warm saline to reduce the air-gap between the probe and the liver’s 
surface. We separately scanned the hepatic flow in the portal vein and in the hepatic artery 
in the anterior segment of the liver and the middle hepatic vein before the hepatic 
transection. The parameters of the hepatic flow were the maximum velocity (max), the 
minimum (min) velocity, the endo-diastolic (ed) velocity, the peak-systolic (ps) velocity, 
the mean velocity, the pulsatility index (PI), the resistance index (RI) and the 
systolic/diastolic ratio (sd) of the portal vein and the hepatic artery (the secondary trunk 
of the anterior sector) and the trunk of the middle hepatic vein.  
 
2.4.    Statistical analysis 
Continuous data are expressed as the mean ± the SD. The data from the different 
groups were compared using a one-way analysis of variance and examined by 
Mann-Whitney’s U-test. The comparison of the continuous data between groups was 
performed using Dunnet’s multi-comparison analysis. The correlation between the 
continuous data was evaluated by a Pearson’s correlation analysis, and the correlation 
coefficient (r) was calculated. A two-tailed p value < 0.05 was considered to be 
statistically significant. The Statistical Package for the Social Science (SPSS) version 
18.0 software (SPSS, Chicago, IL) was used for all statistical analyses.  
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3. Results 
3.1.  Clinicopathological parameters, portal pressure and US Doppler parameters 
Patient demographics and clinicopathological parameters were shown in Table 1. The 
preoperative liver function in the 30 patients was as follows: total bilirubin level, 
0.82±0.39 mg/dl; alanine aminotransferase, 30±18 IU/l; platelet count, 18±6 x 104/mm3; 
prothrombin activity, 92±10%; ICGR15, 10.9±5.9%; LHL15, 0.93±0.03; and HA, 83±64 
ng/ml. All patients showed Child-Pugh grades of A. The intra-operative blood loss was 
806±711 ml (15-2400 ml), and blood transfusions were performed in five patients. 
Postoperative complications were observed in two patients, including liver failure in one 
patient and an intra-abdominal infection in one patient. The staging of histological 
fibrosis was 0 in 19 patients, 1 in six patients, 2 in three patients and 4 in two patients. The 
grading of the histological necro-inflammatory responses was 0 in 18 patients, 1 in 10 
patients and 2 in two patients. 
IOUS Doppler liver scans were performed for all patients. No complications for 
measuring the direct portal pressure were registered in the present series. The portal 
pressure (PP) ranged between 4 and 18 mmHg, and the mean PP was 10.4±4.1 mmHg 
(Table 1). The PP in the normal liver was 10.8±4.3 mmHg, 8.3±3.4 mmHg in 
chemotherapy-associated steatohepatitis, 8 mmHg in fatty liver and obstructive jaundice, 
7 mmHg in hepatolithiasis and 11.8±4.5 mmHg in chronic viral hepatitis, but there were 
no statistically significant differences between the groups. All of the US Doppler 
parameters of the 30 patients are summarized in Table 2. 
 
3.2. Correlations between the liver functional parameters or the US Doppler parameters 
and the PP 
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Table 3 shows the correlations between the PP and the other comparable parameters. 
The correlation analysis identified five variables as significantly negatively correlated 
with PP: the PV max, PV min, PV ed, PV ps and the PV mean (p<0.05). The platelet 
counts tended to be negatively correlated with the PP but were not significant. Other 
parameters were not correlated with the PP in these 30 patients. Five US Doppler 
parameters were required for the multivariable analysis to predict PP before hepatectomy. 
 
3.3. Development of the predictive formula of portal pressure 
The five selected preoperative parameters were examined for correlations with PP 
using a multiple linear regression analysis with the stepwise method (Table 4). After four 
steps, the two parameters of PV max and PV min were still significant (see model 4 in 
Table 3). Based on this result, the regression equation was established as: 
Y (estimated PP) = 18.235 -0.120× (PV max.) -0.364× (PV min) 
 
3.4. Correlation between predictive portal pressure and actual portal pressure 
The mean estimated PP using the predictive formula was 10.44±2.61 mmHg (range 
3.9-14.3 mmHg), which was lower than the actual PP (10.43±4.07 mmHg) (Table 1). The 
correlation between the actual PP and the estimated PP was statistically significant 
(correlation coefficient, 0.642; p<0.001). The calculated PP was not significantly 
associated with the occurrence of postoperative complications (data not shown). A 
significant correlation between the blood loss and the calculated PP was not observed 
(correlation coefficient, 0.006; p=0.98). 
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4.  Discussion 
Portal hypertension is the most important consequence of cirrhosis, and its presence 
represents a hard endpoint for clinical outcomes such as varices, ascites, hepatorenal 
syndrome and encephalopathy [20]. The current standard for measuring portal 
hypertension and severity is usually the measurement of the hepatic venous pressure 
gradient. Measurement of this gradient is safe and relatively simple to perform, but it is 
invasive and costly [6, 7]. Some of the surrogate hepatic markers correlating with PP have 
been examined because portal hypertension reflects hepatic dysfunctions [21, 22]. Zhang 
et al. and Wiechowska-Kozłowska et al. recently reported the usefulness of measuring the 
Doppler flow to evaluate portal hypertension [23, 24]. Other investigators also examined 
the parameters of ultrasonic Doppler flow. However, distinct predictors representing PP 
have yet to be clarified. 
The present study applied the reliable liver function markers of ICGR15, 99mTc-GSA 
liver scintigraphy and serum HA levels as well as conventional parameters [13, 14, 17, 
18]. The ICGR15 and LHL15 from the 99mTc-GSA liver scintigraphy have been applied 
recently to evaluate the indications for surgical resection as a reliable marker [14, 17, 18, 
25]. Our report showed a close correlation between the functional volumetry by 
99mTc-GSA scintigraphy and PP [25], suggesting that HH15 and LHL15 are reliable 
predictors of PP. Serum HA is a marker of hepatic fibrosis and the deserialization of 
endothelial cell function in the liver [13], which reflect post-hepatectomy complications, 
such as hepatic failure [13, 26] that was caused by portal hypertension. However, in the 
small size of the present series, these parameters were not well correlated with PP. The 
platelet count tended to be negatively correlated with PP in the present study. The lower 
platelet counts reflected the severity of the hepatic damages related to high PP [27]. A 
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previous study showed that platelet counts were markedly decreased according to the 
severity of portal hypertension [28]. 
By applying the US Doppler examinations, six parameters closely correlated with PP 
were identified. Among these parameters, the velocity of the portal flow was significantly 
associated with the PP value. In cases of portal hypertension, the velocity of the hepatic 
vein was expected to be decreased and flattened, and the arterial flow was expected to be 
increased [29]. However, in the present study, none of the hepatic artery and vein 
parameters were well correlated. Thus, portal velocity would be directly influenced by 
the PP. The location of the measurement may have an effect, although we measured the 
vessels in which the vertical flows could be easily observed. The portal flow velocities 
were negatively correlated with the PP in the present results, as indicated in the previous 
reports [29]. By applying these parameters, the prediction of PP would be possible. In 
selecting six parameters that could be evaluated preoperatively, the present study 
attempted to create a comprehensively predictive formula. To the best of our knowledge, 
an attempt to develop such a formula has not been fully reported. As a result of the 
multiple regression analysis, a formula for applying the two parameters of PV max. and 
PV min was developed but not for the mean velocity, RI or PI.  
By comparing the calculated PP with the actual PP, a strong correlation could be 
clarified even though both the calculated PP and the actual PP were not always the same 
in each patient; thus, the calculated PP can be used to predict an estimated PP. To evaluate 
portal hypertension, the cut-off value should be established. As the definition of the upper 
limit of normal PP was 15 cmH2O (approximately 11 mmHg), an estimated PP >11 
mmHg was also thought to indicate an actual PP >11 mmHg. An actual PP >11 mmHg 
was observed in 17 patients (57%), whereas an estimated PP >11 mmHg was observed in 
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14 patients. We believed that the calculated PP would be almost similar to the actual PP 
according to the present results. The relationship between the clinical outcomes and the 
calculated PP was considered to predict postoperative morbidity; however, 
hepatectomy-associated complications according to high PP were observed in only two 
patients in the present study. The correlation between the intra-operative blood loss and 
the calculated PP was not significant. To clarify the clinical significance of calculating the 
predictive PP from the US Doppler, a future study in a larger number of patients who have 
cirrhosis with portal hypertension or who had post-hepatectomy complications should be 
undertaken. 
The usefulness of IOUS has been well established, and IOUS is considered a reliable 
imaging technique that is often used to confirm the diagnosis of intrahepatic tumor 
lesions [3, 4]. The advantages of IOUS Doppler were recently reported in patients 
undergoing hepatectomy [10-12]. In the present study, we assessed the usefulness of 
IOUS Doppler in the detection of portal hypertension in a preliminary study. Ideally, the 
measurement of the preoperative US would be useful to predict the operative risk of an 
increased PP. However, the extracorporeal US was often limited by the bowel gas or by 
the patients’ physiques if they were obese. Based on this preliminary study, the usefulness 
of measuring the PV velocity with the IOUS Doppler to predict the PP was estimated; 
therefore, a further study with a larger number of patients will be necessary in the future. 
In recent years, hepatic elastography using a Fibroscan has been developed to detect liver 
injury or hepatic fibrosis [30]. The relationship between the PP and such a new diagnostic 
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In conclusion, we have demonstrated that the IOUS Doppler allows us to evaluate the 
correlation with the portal pressure and to assist in making decisions about hepatic 
resections. Thirty patients underwent the measurement of PP during hepatic resections 
using intra-operative Doppler US parameters A predictive formula for PP using the portal 
flow velocity was determined, and the calculated values showed positive correlations 
with the true PP. As a relationship between the calculated PP and the postoperative 
outcomes or blood loss was not observed, a future study in a larger number of subjects 
using the present formula is needed. This imaging modality could become a useful 
surrogate procedure to evaluate portal hypertension in patients with various liver diseases 
who undergo hepatectomy. 
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Table 1 Patient background, clinicopathological data and the measured portal pressures 



























1 54 f CCC normal 1080 n 15.0  0.93  1.1  20  13  87  95 0  0  17 14.12  
2 69 m HCC normal 740 n 8.6  0.88  0.4  42  26  97  45  2  1  4 7.22  
3 30 m MLC normal 1400 n 1.2  0.98  0.7  60  16  77  23  0  0  18 11.23  
4 64 f BDC normal 860 n 8.9 0.94 0.5  19  16  111  43 0  0  9 6.32  
5 65 m BDC jaundice 850 LF 10.9  0.93  2.1  52  22  102  48 0  0  8 6.26  
6 36 f HCC normal 150 n 5.0  0.95  1.5  12  27  75  67 0  0  5 7.17  
7 72 m MLC CASH 180 n 15.3  0.93  1.4  10  12  78  151  0  0  5 8.56  
8 80 m MLC CASH 480 n 9.7  0.96  0.3  30  6  90  67  0  0  8 9.68  
9 85 f MLC normal 430 n 7.1  0.86  0.7  15  25  96  84  0  0  12 13.03  
10 67 m HCC normal 1700 n 12.5  0.90  0.6  40  13  93  268  1  1  12 9.35  
11 65 f BDC normal 1450 infection 6.5 0.94 0.8  14  26  89  23  0  0  6 10.80  
12 63 f HCC CVH 480 n 14.0  0.93  0.7  46  20  105  107  1  1  10 12.32  
13 67 m HCC CVH 870 n 13.5  0.92 1.1  16  17  88  110 4  1  14 14.29  
14 58 m HCC CVH(cirrhosis) 2400 n 26.8  0.88  1.1  35  7  82  189  4  2  14 13.59  
15 84 f MLC normal 200 n 9.0  0.92  0.5  12  14  88  52  0  0  5 8.54  
16 64 f MLC normal 350 n 9.0  0.94  0.8  23  15  95  45  0  0  16 12.28  
17 76 m HCC CVH 820 n 10.2  0.96  0.9  49  14  88  60  2  1  10 7.73  
18 56 m BDC normal 920 n 10.5 0.95 1.3  85  19  86  78 0  0  8 11.04  
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19 68 m HCC normal 180 n 6.6  0.93  0.6  27  20  84  56  0  1  12 12.55  
20 82 m HCC normal 1930 n 18.1  0.95  0.7  22  14  105  111  1  1  13 9.63  
21 62 m HCC CVH(cirrhosis) 2030 n 13.8  0.94  0.5  26  18  93  101  1  1  14 12.61  
22 85 m HCC fatty 15 n 11.0  0.96  0.6  15  27  76  97  1  2  8 9.72  
23 74 m MLC CASH 850 n 7.0  0.94  0.3  18  19  92  115 0  0  13 13.30  
24 67 m HCC CVH 2000 n 18.8  0.94  1.1  59  13  100  26  2  1  5 3.94  
25 72 m HCC normal 230 n 8.9  0.93  1.0  15  17  96  45  1  1  12 12.45  
26 74 m CCC normal 50 Infection 3.4  0.94  0.8  27  20  112  16  0  0  11 9.94  
27 58 f BDC hepatolithiasis 890 n 2.5  0.95  0.7  36  29  114  23  0  0  7 10.20  
28 59 m CCC normal 750 n 4.0  0.93  0.6  16  14  88  98 0  0  12  12.98  
29 40 m MLC CASH 700 n 9.8  0.95  0.4  23  19  87  45 0  0  7  11.83  
30 68 m HCC CVH 110 n 21.4  0.89  0.8  44  18  89  154  0 0 18  10.46  
ICG: indocyanine green, LHL15: liver uptake ratio at 15 minutes 
CCC: cholangiocellular carcinoma, HCC: hepatocellular carcinoma, MLC: metastatic liver carcinoma, BDC: bile duct 
carcinoma, CVH: chronic viral hepatitis, CASH: chemotherapy-associated steatohepatitis, LF: liver failure
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Table 2  Each parameter of ultrasonographic Doppler 
 Portal vein Hepatic artery Hepatic vein 
Maximum (m/sec.) 28.4±11.5 52.6±21.2 -16.2±25.0 
Minimum (m/sec.) 12.1±4.9 17.9±9.0 -4.2±12.5 
Endo-diastolic (m/sec) 15.6±6.1 22.2±11.8 -5.9±10.9 
Peak-systolic (m/sec.) 16.4±6.6 32.7±15.9 -7.7±10.9 
Mean (m/sec.) 7.5±3.6 14.8±6.9 -4.0±4.7 
Pulsatility index 0.84±0.66 0.96±0.47 1.92±1.33 
Resistance index 0.47±0.28 0.61±0.31 0.74±0.34 
Systolic/diastolic ratio 2.09±0.84 2.94±2.47 4.30±9.70 
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Table 3 Correlations between portal pressure and clinicopathological or liver functional parameters and parameters of 






Total bilirubin (mg/dl) 
Alanine transaminase (IU/L) 
Platelet count (/mm3) 
Prothrombin activity (%) 
Hyaluronic acid (ng/ml) 
PV maximum (max.) 
PV minimum (min.) 
PV endo-diastolic (ed.) 
PV peak-systolic (ps.) 
PV mean 
PV pulsatility index (PI) 
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Staging (degree of fibrosis) 
Grading (necroinflammatory response) 
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Data are presented by the correlation coefficient (r value). 
PV; portal vein, HA; hepatic artery, HV; hepatic vein 
ICG: indocyanine green, LHL15: liver uptake ratio at 15 minutes  
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Table 4 Multiple linear regression stepwise method output using US Doppler data for correlations with portal pressure 
Model Unstandardized coefficients Standardized coefficient 
t value P value 
95% confidence interval 
ß Standard error ß lower limit upper limit 
1 (Constant) 18.303 2.025  9.038 .000 14.123 22.482 
PV max. -.097 .073 -.275 -1.323 .198 -.249 .054 
PV min. -.350 .225 -.421 -1.558 .132 -.814 .114 
PV ed. .020 .238 .030 .085 .933 -.471 .512 
PV ps. -.094 .209 -.152 -.449 .657 -.526 .338 
PV mean .046 .290 .041 .159 .875 -.553 .646 
2 (Constant) 18.324 1.969  9.306 .000 14.268 22.379 
PV max. -.098 .071 -.277 -1.372 .182 -.245 .049 
PV min. -.343 .203 -.412 -1.688 .104 -.761 .075 
PV ps. -.083 .156 -.133 -.529 .601 -.403 .238 
PV mean .051 .279 .046 .184 .856 -.523 .625 
3 (Constant) 18.336 1.931  9.496 .000 14.367 22.306 
PV max. -.100 .069 -.284 -1.450 .159 -.242 .042 
PV min. -.320 .158 -.385 -2.021 .054 -.646 .005 
PV ps. -.073 .144 -.117 -.506 .617 -.369 .223 
4 (Constant) 18.235 1.894  9.628 .000 14.349 22.121 
PV max. -.120 .056 -.340 -2.156 .040 -.235 -.006 
PV min. -.364 .131 -.437 -2.766 .010 -.633 -.094 
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Dependent variable is portal pressure (mmHg). PV; portal vein max; maximum, min; minimum, ed; endo-diastolic, ps; peak systolic 
Dependent variable: Step 4 total. The standardized ß coefficient provides a measure of the contribution of each variable to the model.  
The t and p values provide an indication of the impact of each predictor variable.  
 
